California State Teachers Retirement System Has $3.94 Million Holdings in ICU Medical, Inc. $ICUI

Key Points

• California State Teachers Retirement System reduced its ICU Medical stake by 2.2% to 26,905 shares, valued at approximately $3.94 million. Institutional investors collectively own 96.1% of the company, with BlackRock and Jupiter Topco among the major recent investors.
• ICU Medical reported quarterly EPS of $2.37, exceeding the $1.91 consensus estimate, while revenue reached $547.88 million. The company issued fiscal 2026 EPS guidance of $8.60–$9.00.
• Analysts maintain a “Moderate Buy” consensus rating with an average price target of $192.80, although company insiders sold 21,830 shares worth about $3.91 million during the last quarter.

California State Teachers Retirement System trimmed its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 2.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,905 shares of the medical instruments supplier's stock after selling 607 shares during the quarter. California State Teachers Retirement System owned approximately 0.11% of ICU Medical worth $3,944,273 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in ICUI. BlackRock Inc. bought a new stake in shares of ICU Medical during the 2nd quarter valued at about $550,250,000. Jupiter Topco LLC acquired a new stake in ICU Medical in the second quarter worth about $407,786,000. Janus Henderson Group PLC boosted its holdings in ICU Medical by 3.9% during the first quarter. Janus Henderson Group PLC now owns 2,676,012 shares of the medical instruments supplier's stock worth $345,607,000 after buying an additional 99,256 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of ICU Medical by 6.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 983,802 shares of the medical instruments supplier's stock worth $127,053,000 after purchasing an additional 63,026 shares during the last quarter. Finally, Norges Bank purchased a new stake in ICU Medical during the fourth quarter worth about $58,083,000. 96.10% of the stock is currently owned by institutional investors.

ICU Medical Stock Performance

ICU Medical stock traded down $0.57 during midday trading on Tuesday, hitting $157.03. 82,992 shares of the company were exchanged, compared to its average volume of 287,167. The firm has a market capitalization of $3.92 billion, a PE ratio of 132.85, a price-to-earnings-growth ratio of 1.98 and a beta of 0.75. ICU Medical, Inc. has a fifty-two week low of $112.50 and a fifty-two week high of $192.85. The business has a fifty day simple moving average of $168.32 and a two-hundred day simple moving average of $145.21. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.21 and a current ratio of 2.43.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $2.37 earnings per share for the quarter, beating the consensus estimate of $1.91 by $0.46. ICU Medical had a return on equity of 7.91% and a net margin of 1.39%.The business had revenue of $547.88 million during the quarter, compared to the consensus estimate of $533.44 million. During the same period in the prior year, the company earned $2.10 earnings per share. The company's revenue was up .5% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. On average, sell-side analysts forecast that ICU Medical, Inc. will post 7.19 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on ICUI shares. Needham & Company LLC boosted their price objective on shares of ICU Medical from $165.00 to $187.00 and gave the company a "buy" rating in a research report on Friday, August 7th. KeyCorp upped their price objective on ICU Medical from $164.00 to $182.00 and gave the company an "overweight" rating in a research note on Tuesday, July 21st. BTIG Research upped their target price on shares of ICU Medical from $170.00 to $200.00 and gave the stock a "buy" rating in a research note on Friday, August 7th. Zacks Research downgraded shares of ICU Medical from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, July 28th. Finally, Weiss Ratings raised ICU Medical from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Thursday, July 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $192.80.

Insider Buying and Selling at ICU Medical

In related news, VP Daniel Woolson sold 5,417 shares of the stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $181.33, for a total value of $982,264.61. Following the completion of the sale, the vice president directly owned 17,062 shares in the company, valued at $3,093,852.46. This represents a 24.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Christian Voigtlander sold 8,929 shares of the business's stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $182.93, for a total transaction of $1,633,381.97. Following the completion of the transaction, the chief operating officer owned 37,377 shares in the company, valued at approximately $6,837,374.61. The trade was a 19.28% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 21,830 shares of company stock valued at $3,905,003 in the last quarter. 2.10% of the stock is currently owned by corporate insiders.

About ICU Medical

ICU Medical, Inc develops, manufactures and sells medical devices used in infusion therapy, critical care and oncology. Its product portfolio includes infusion pumps, IV administration sets, needle-free connectors, vascular access devices, patient monitoring equipment and related accessories designed to support the delivery of fluids and medications and the monitoring of patients in healthcare settings.

The company also provides products for the safe handling of hazardous drugs, including closed-system transfer devices used in oncology and pharmacy operations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.